Search results for pharmaceuticals
FiltersOpen Government Canada
Portal
132 datasets for “pharmaceuticals”
- Open Government Canada
Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: Q10: Pharmaceutical Quality System
Health Canada | Santé CanadaUpdated 2 Nov 2023
Q10: Pharmaceutical Quality System. This guidance has been developed by the appropriate ICH Expert Working Group and has …
- HTML
- Open Government Canada
Service Standards for Drug Submission Evaluations (Pharmaceuticals and Biologic Products) under the Food and Drug Regulations - Health Canada
Health Canada | Santé CanadaUpdated 3 Sept 2023
Service Delivery Standards.
- HTML
- Open Government Canada
Guidance document on the application for a certificate of a pharmaceutical product and good manufacturing practice certificate (GUI-0024)
Health Canada | Santé CanadaUpdated 29 Dec 2021
This document clarifies the requirements to be met for the issuance of a Certificate of a Pharmaceutical Product …
- HTML
- Open Government Canada
Notice of publication: Good manufacturing practices guidelines for active pharmaceutical ingredients
Health Canada | Santé CanadaUpdated 27 Feb 2023
On February 10, 2022, the Health Product Compliance Directorate posted Good manufacturing practices guidelines for active pharmaceutical ingredients …
- HTML
- Open Government Canada
Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime
Health Canada | Santé CanadaUpdated 17 Sept 2020
The pharmaceutical company must complete and submit to the Commissioner of Patents one of the forms listed below …
- HTML
- Open Government Canada
Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104) - Summary
Health Canada | Santé CanadaUpdated 27 Feb 2023
This guide is for people who work with Active Pharmaceutical Ingredients (APIs) and their intermediates to understand and …
- HTML
- Open Government Canada
Guidance Document - Quality (Chemistry and Manufacturing) Guidance: Clinical Trial Applications (CTAs) for Pharmaceuticals
Health Canada | Santé CanadaUpdated 2 Jun 2021
To assist submission sponsors in preparing Clinical Trial Applications (CTAs) filed with Health Canada by outlining the Quality …
- HTML
- Open Government Canada
Guidance Document - Pharmaceutical Development ICH Topic Q8(R2)
Health Canada | Santé CanadaUpdated 2 Dec 2023
This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation …
- HTML
- Open Government Canada
Safety Pharmacology Studies for Human Pharmaceuticals ICH Topic S7A
Health Canada | Santé CanadaUpdated 2 Dec 2023
This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation …
- HTML
- Open Government Canada
Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q9: Quality Risk Management
Health Canada | Santé CanadaUpdated 1 Nov 2023
Q9: Quality Risk Management. This guidance has been developed by the appropriate ICH Expert Working Group and has …
- HTML
- Open Government Canada
Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance
Health Canada | Santé CanadaUpdated 1 Nov 2023
Q8, Q9 and Q10 Questions & Answers (R4). This guidance has been developed by the appropriate ICH Expert Working …
- HTML
- Open Government Canada
M3(R2): Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
Health Canada | Santé CanadaUpdated 2 Dec 2023
… to support human clinical trials of a given scope and duration as well as marketing authorization for pharmaceuticals.
- HTML
- Open Government Canada
Guidance Document: Labelling of Pharmaceutical Drugs for Human Use
Health Canada | Santé CanadaUpdated 7 Jul 2021
The purpose of this document is to provide guidance to sponsors to facilitate compliance with the labelling requirements …
- HTML
- Open Government Canada
Toxicity of the pharmaceuticals finasteride and melengestrol acetate to the mayfly Hexagenia spp.
Environment and Climate Change Canada | Environnement et Changement climatique CanadaUpdated 16 May 2023
The toxicity of pharmaceuticals finasteride (FIN) and melengestrol acetate (MGA) was assessed in chronic (42 days) sediment tests …
- HTML
- Open Government Canada
Draft Guidance for Industry: Quality Guidance: Applications for Drug Identification Numbers (DINAs) for Pharmaceuticals
Health Canada | Santé CanadaUpdated 3 Sept 2023
This document is intended to provide guidance with respect to the Quality (Chemistry and Manufacturing) portion of Applications …
- HTML
- Open Government Canada
Toxicity of the pharmaceuticals finasteride and melengestrol acetate to the amphipod Hyalella azteca
Environment and Climate Change Canada | Environnement et Changement climatique CanadaUpdated 24 Jan 2022
The toxicity of pharmaceuticals finasteride (FIN) and melengestrol acetate (MGA) was assessed in chronic (42 days) sediment tests …
- HTML
- Open Government Canada
Updated: Notice - Notification of Safety Labelling Changes to the Product Monographs of Pharmaceutical Drug Products
Health Canada | Santé CanadaUpdated 29 Dec 2021
… new safety information in PMs of brand name pharmaceutical drug products (those regulated under Division 8 of the …
- HTML
- Open Government Canada
Guidance Document - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Impurities in New Drug Substances - ICH Topic Q3A(R2)
Health Canada | Santé CanadaUpdated 2 Dec 2023
This document is intended to provide guidance for registration applications on the content and qualification of impurities in …
- HTML
- Open Government Canada
Guidance Document: Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only)
Health Canada | Santé CanadaUpdated 7 Jul 2021
… These new drugs may include pharmaceuticals, biologics, and radiopharmaceuticals for human use, including those submissions for which a …
- HTML
- Open Government Canada
Notice: Health Canada and United States Food and Drug Administration Joint Public Consultation on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guidelines
Health Canada | Santé CanadaUpdated 29 Dec 2021
… International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines currently under development. The …
- HTML